These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3887670)

  • 1. Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits.
    Agarwal RP; McPherson RA; Threatte GA
    Ther Drug Monit; 1985; 7(1):61-5. PubMed ID: 3887670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
    Rosano TG
    Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of cyclosporin A metabolites among plasma and cells in whole blood: effect of temperature, hematocrit, and metabolite concentration.
    Lensmeyer GL; Wiebe DA; Carlson IH
    Clin Chem; 1989 Jan; 35(1):56-63. PubMed ID: 2642763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of cyclosporin A levels with radioimmunoassay in renal transplant recipients: comparison of monospecific and nonspecific assays.
    Lai MK; Tzen KY; Ou YC; Huang CC; Chu SH; Chuang CK; Chen HW; Chen CS
    J Formos Med Assoc; 1993 Nov; 92(11):948-52. PubMed ID: 7910064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of variables contributing to cyclosporine distribution in blood.
    Broin SO; Clarke E; McCann S
    Ir J Med Sci; 1990; 159(9-12):269-71. PubMed ID: 2094690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.
    Lindholm A; Henricsson S
    Ther Drug Monit; 1990 Jul; 12(4):344-52. PubMed ID: 2396308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sample preparation on concentrations of cyclosporin A measured in plasma.
    Yatscoff RW; Rush DN; Jeffery JR
    Clin Chem; 1984 Nov; 30(11):1812-4. PubMed ID: 6488526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of haematocrit on blood cyclosporin measurements in vivo.
    Johnston A; Marsden JT; Holt DW
    Br J Clin Pharmacol; 1988 Apr; 25(4):509-13. PubMed ID: 3382593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of cyclosporine in plasma from patients with various transplants: HPLC radioimmunoassay with a specific monoclonal antibody compared.
    McBride JH; Rodgerson DO; Park SS; Reyes AF
    Clin Chem; 1989 Aug; 35(8):1726-30. PubMed ID: 2667807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclosporin levels in semen of renal transplant patients].
    Pak K; Kim CJ; Ishida A; Kushima M; Tomoyoshi T; Sako T; Okino K; Nakane Y; Kodama M; Shibata N
    Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1494-9. PubMed ID: 2273699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
    Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
    Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
    Kupin WL; Venkat KK; Norris C; Florence-Green D; Dienst S; Oh HK; Feldkamp C; Levin NW
    Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood.
    Arnold AN; Waltzer WC; Anaise D; Weinstein SW; Rapaport FT
    Transplantation; 1985 Dec; 40(6):605-10. PubMed ID: 3907030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized method for measuring cyclosporin A with 125I-labeled cyclosporin.
    Felder RA; Mifflin TE; Bastani B
    Clin Chem; 1986 Jul; 32(7):1378-82. PubMed ID: 3521944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.